Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
Suneetha
S
S
Reddy
R
R
D000293:Adolescent; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D005121:Extremities / Q000382:microbiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D008911:Minocycline / Q000008:administration & dosage; D009166:Mycobacterium leprae / Q000302:isolation & purification; D015242:Ofloxacin / Q000008:administration & dosage; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000382:microbiology / Q000517:prevention & control*; D011256:Pregnancy Outcome; D020551:Pulse Therapy, Drug; D012293:Rifampin / Q000008:administration & dosage; D012867:Skin / Q000382:microbiology; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D007917:Leprostatic Agents; D015242:Ofloxacin; D008911:Minocycline; D012293:Rifampin